Upcoming events

    • 14 Mar 2026
    • 8:30 AM - 4:45 PM
    • Wisteria Hall, Washington Park Arboretum, Seattle, WA
    Register

     PNNS 39th Annual Conference 

    Evaluating Dementia Risk Following
    Traumatic Brain Injury:
    Evidence-Based Clinical and Forensic Perspectives

    C. Munro Cullum, Ph.D., ABPP-CN

    &

    Development and Implementation of Cognitive Remediation Across Clinical and Research Settings

    Donna Murdaugh, PhD, ABPP-CN

    ___________________________________________________________________

    Morning Presentation (9:00 - 12:00)

    Evaluating Dementia Risk Following Traumatic Brain Injury: Evidence-Based Clinical and Forensic Perspectives


    C. Munro Cullum, Ph.D., ABPP-CN
    Professor of Psychiatry, Neurology, and Neurological Surgery,
    University of Texas Southwestern Medical Center

    Dr. Cullum holds the Pam Blumenthal Distinguished Professorship in Clinical Psychology, serves as Vice Chair and Chief of the Division of Psychology in the Department of Psychiatry, and is the Senior Neuropsychologist in the Peter O’Donnell Brain Institute at UT Southwestern. He completed his Ph.D. in Clinical Psychology at the University of Texas at Austin, followed by internship and postdoctoral residency in clinical neuropsychology at the University of California San Diego and the San Diego VA. Dr. Cullum was UT Southwestern’s first board-certified clinical neuropsychologist and is involved in research, education, administration, and clinical service. His research includes short- and long-term effects of concussion, risk factors and differential diagnosis of Alzheimer’s Disease and other neurodegenerative conditions, and cognitive assessment and telehealth applications of neuropsychology. He is the Scientific Director for the Texas Alzheimer’s Research and Care Consortium (TARCC) and is a Fellow and Past-President of the National Academy of Neuropsychology, the Society for Clinical Neuropsychology (APA Division 40), and the Sports Neuropsychology Society.

    Learning Objectives:  At the conclusion of this activity, participants will be able to:

    1. Articulate primary mechanisms and diagnosis of concussion / mild traumatic brain injury
    2. Identify the primary methodological challenges in studying TBI in relation to later-life dementia risk
    3. Critically evaluate the literature and summarize current conclusions regarding the relationship between traumatic brain injury and dementia risk
    4. Define chronic traumatic encephalopathy (CTE) and explain its relevance and limitations within clinical and forensic  applications
    5. Recognize and articulate the limitations of extrapolating clinical research findings on traumatic brain injury and dementia to forensic contexts

    ________________________________________________

    Afternoon Presentation (1:30 - 4:30)

    Development and Implementation of Cognitive Remediation Across Clinical and Research Settings


    Donna Murdaugh, PhD, ABPP-CN
    Institute for Cancer Outcomes & Survivorship
    Department of Pediatrics, Heersink School of Medicine
    The University of Alabama at Birmingham

    Dr. Murdaugh is a board certified clinical neuropsychologist who is focused on research involving understanding and improving neurocognitive outcomes in pediatric and young adult cancer survivors. Dr. Murdaugh’s interests include: understanding long-term neurocognitive outcomes in cancer survivors utilizing neuropsychological assessment and multimodal neuroimaging, developing a risk prediction model to identify cancer patients at greatest risk for neurocognitive deficits, and developing targeted cognitive remediation interventions to improve cognitive functioning in cancer survivors.

    Learning Objectives

    1. Describe a neurocognitive outcome model as a framework for clinical and research applications for developing targeted interventions to improve cognitive outcomes.
    2. Effectively describe the key components and principles of a cognitive remediation program, with a particular focus on supporting transition readiness aged youth.
    3. Identify strategies for tailoring interventions to specific medical populations, such as cancer and blood disorders, and to meet the diverse needs of patients and families.


      • 11 May 2026
      • 7:00 PM - 9:00 PM
      • Zoom

      Biomarkers and Monoclonal Antibody Treatment in AD


      Cierra Keith, PhD, ABPP-CN
      Assistant Professor, Department of Behavioral Medicine & Psychiatry
      West Virginia University School of Medicine

      Dr. Cierra Keith has been named as the inaugural Dementia SIG Co-Chair for the American Academy of Clinical Neuropsychology's new condition-based Special Interest Groups (SIGs) for Brain Injury and Dementia!

      An assistant professor and clinical neuropsychologist at the RNI, Dr. Keith has extensive experience with monoclonal antibody therapy for Alzheimer’s disease. She actively researches neuroimaging and cognitive aspects of Alzheimer’s and other neurodegenerative conditions and participates in clinical trials.


    Past events

    12 Jan 2026 Dementia in Autistic Adults During Midlife: An Overview of Risk Factors, Prevalence Rates, and Considerations for Diagnostic Evaluations
    10 Nov 2025 Risk Concerns and Neurocognitive Disorders: Clinical and Ethical Perspectives on Suicide and Driving
    8 Sep 2025 The Intersection of Altered Trajectories and Pediatric Clinical Practice Models: How Can Neuropsychologists Meet the Moment
    12 May 2025 ADHD in Girls and Women
    8 Mar 2025 PNNS 38th Annual Conference
    13 Jan 2025 Evidence-based Assessment and Active Treatment of Concussion: The Central Role of Neuropsychology
    18 Nov 2024 Transcranial Magnetic Stimulation (TMS) with Psychiatric and Neurological Disorders
    9 Sep 2024 Incorporating Gender-affirming Care Into Neuropsychological Practice
    13 May 2024 Complex Persistent Symptoms after COVID
    9 Mar 2024 PNNS ANNUAL CONFERENCE
    8 Jan 2024 Conversion (Functional Neurologic) Disorder: Past, Present, and Future
    13 Nov 2023 Core Ethical Issues in Work with Older People
    11 Sep 2023 Neuropsychological Evaluations with the Advanced Clinical Solutions (ACS) Battery
    8 May 2023 Cognition and Sleep and Sleep Disorders
    4 Mar 2023 2023 Annual PNNS Zoom Conference
    9 Jan 2023 The Role of Midbrain-Hippocampus Structural Connectivity on Motivated Memory Encoding
    14 Nov 2022 COVID and the Brain
    12 Sep 2022 Lab Values and Cognitive Functioning
    13 Jun 2022 Special PNNS Membership Meeting
    9 May 2022 Ethics & Equity In Neuropsychology: Practical and practice-based methods to increase both business growth and community access among diverse populations
    5 Mar 2022 2022 Annual PNNS Virtual Meeting
    7 Feb 2022 Special Ethics Interactive Workshop--Advocating for Neuropsychology in Washington State and Why it Matters
    10 Jan 2022 Longitudinal Research on Two Common Brain-Related Conditions in Children: Findings and Implications
    8 Nov 2021 Maximizing Cognitive Health and Memory in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Dementia
    25 Oct 2021 Special Ethics CE Discussion: Safe and Responsible Neuropsychological Practice During an Epidemic and Public Health Emergency
    13 Sep 2021 Perspectives and the Incidence, Complications, and Pathophysiology of Psychosis in Dementias and in Parkinson's
    10 May 2021 The Clinical Management of Individuals Presenting with Mild Traumatic Brain Injury
    12 Apr 2021 PNNS - Professional Issues and Networking Event
    13 Mar 2021 Annual PNNS Virtual Meeting
    11 Jan 2021 Alzheimer’s Disease Diagnosis, Biomarkers, and Clinical Heterogeneity


    Copyright 2021, www.pnns.org.  Contact postmaster@pnns.org for information and questions. 

    Powered by Wild Apricot Membership Software